Dividend King Altria Recently Raised Its Quarterly Dividend by Nearly 5%. Is the Stock a Buy?

Altria raised its quarterly dividend 4.7% to $1.11 per share, or $4.44 annualized, implying a yield above 6.5% and extending its 57-year dividend-growth streak. However, first-half 2026 free cash flow was nearly $2.9B, below roughly $3.6B of dividends paid, while cash declined from about $4.5B at year-end 2025 to $2.4B at June 30. Revenue rose 1.6% to more than $11.5B and adjusted EPS increased nearly 5%, but smokeable and oral tobacco shipment volumes fell 2.7% and 6%, respectively, leaving dividend sustainability dependent on continued cash-flow resilience.

Analysis

MO’s equity case is increasingly a capital-allocation arbitrage rather than a growth story: preserving the dividend absorbs most available cash generation while cigarette downtrading limits pricing-led margin expansion. The key risk is not an imminent cut—management has substantial incentive to protect its income-investor base—but a reduction in buybacks, incremental leverage, or a flatter dividend-growth cadence. Any of these would weaken the valuation support typically assigned to a 6%+ yield.

The more important competitive read-through is that value-seeking consumers favor discount combustible brands, while nicotine-pouch growth is fragmenting toward scaled, premium global platforms. PM has a cleaner medium-term pathway to smoke-free mix expansion through IQOS/ZYN exposure, whereas MO must fund pouch share gains against a declining legacy cash engine. If MO responds with promotional intensity in on!, the likely result is lower category profitability before meaningful share gains.

Over the next 1-3 months, the decisive datapoints are second-half operating cash flow conversion, working-capital normalization, and whether cash rebuilding avoids additional debt issuance. Over 6-18 months, the thesis turns on whether smoke-free net revenue can grow fast enough to offset volume decline without materially raising marketing spend. A sustained deterioration in FCF/dividend coverage or a shift in dividend policy language would likely cause income holders to reprice MO sharply, as the yield cushion would become a warning signal rather than support.

Contrarianly, the market may already discount a slow erosion scenario: if second-half cash conversion normalizes and pricing remains intact, MO can sustain the payout despite weak first-half optics. That outcome supports range-bound carry, not necessarily multiple expansion; the upside case requires evidence that on! can gain share profitably rather than merely grow volume.

Key Decisions for Investors

• Maintain an underweight in MO versus PM over a 6-18 month horizon. Express as long PM / short MO in equal dollar terms; PM offers superior reduced-risk-product optionality, while MO bears greater dividend-coverage and U.S. downtrading risk. Reassess if MO reports second-half FCF covering dividends by at least 1.1x and on! growth accelerates without gross-margin erosion.
• Do not short MO solely on first-half cash flow. Set an event-driven alert around the next earnings release: a lowered full-year cash-flow outlook, weaker buyback authorization, incremental net-debt increase, or softer dividend-growth commentary would be a catalyst for a 8-12% downside repricing.
• For yield-focused exposure, wait for confirmation of second-half cash rebuilding before adding MO. The appropriate entry condition is evidence that working-capital seasonality—not underlying operating deterioration—explains the coverage gap; absent that, the nominal yield does not compensate for potential multiple compression.
• Monitor U.S. nicotine-pouch pricing and promotional activity over the next two quarters. Material discounting by MO or major pouch competitors would invalidate the assumption that smoke-free growth can replace combustibles at comparable margins and would strengthen the PM-over-MO pair.